Comment on: Takeda et al. Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice. Diabetes 2013;62:223-233

Comment

Kavaljit H Chhabra et al. Diabetes. 2013 Jul.

. 2013 Jul;62(7):e9.

doi: 10.2337/db13-0389.

No abstract available

Comment in

Response to comment on: Takeda et al. Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice. Diabetes 2013;62:223-233.
Yamamoto K, Takeda M, Ohishi M, Rakugi H. Yamamoto K, et al. Diabetes. 2013 Jul;62(7):e10. doi: 10.2337/db13-0505. Diabetes. 2013. PMID: 23801721 Free PMC article. No abstract available.

Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice.
Takeda M, Yamamoto K, Takemura Y, Takeshita H, Hongyo K, Kawai T, Hanasaki-Yamamoto H, Oguro R, Takami Y, Tatara Y, Takeya Y, Sugimoto K, Kamide K, Ohishi M, Rakugi H. Takeda M, et al. Diabetes. 2013 Jan;62(1):223-33. doi: 10.2337/db12-0177. Epub 2012 Aug 29. Diabetes. 2013. PMID: 22933108 Free PMC article.

1. Takeda M, Yamamoto K, Takemura Y, et al. Loss of ACE2 exaggerates high-calorie diet–induced insulin resistance by reduction of GLUT4 in mice. Diabetes 2013;62:223–233 - PMC - PubMed
1. Chhabra KH, Xia H, Pedersen KB, Speth RC, Lazartigues E. Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice. Am J Physiol Endocrinol Metab 2013;304:E874–E884 - PMC - PubMed
1. Niu M-J, Yang J-K, Lin S-S, Ji X-J, Guo L-M. Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice. Endocrine 2008;34:56–61 - PubMed
1. Bindom SM, Lazartigues E. The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol 2009;302:193–202 - PMC - PubMed
1. Bindom SM, Hans CP, Xia H, Boulares AH, Lazartigues E. Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice. Diabetes 2010;59:2540–2548 - PMC - PubMed